 
                                  Shrinidhi Nathany: Patients with CHIP May Be Predisposed to Higher Risk of Cytokine Release Syndrome after CAR-T
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, shared a post on LinkedIn:
“New Research Alert!!!!!!!
CHIP Mutations May Amplify Inflammation in CAR-T Therapy
A fascinating new study (Zhang et al., J Transl Clin Transplant 2025) reveals that CRISPR knockdown of CHIP genes (DNMT3A, TET2, ASXL1) in macrophages drives increased production of inflammatory cytokines during CAR-T cell therapy including IL-6, MCP-1, and IL-1β.
Translation?
Patients with Clonal Hematopoiesis of Indeterminate Potential (CHIP) may be predisposed to higher risk of Cytokine Release Syndrome (CRS) after CAR-T.
This could reshape how we risk-stratify, monitor, and personalize CAR-T therapy especially in multiple myeloma and hematologic malignancies.”
Title: CRISPR knockdown of CHIP genes in macrophages drives increased production of inflammatory cytokines in CAR-T cell therapy
Authors: Chunyan Zhang, Scott R. Goldsmith, Myo Htut, June-Wha Rhee, Vibhuti Vyas, Mary C. Clark, Saro H. Armenian, Stephen J. Forman, Xiuli Wang

Read the full article.
Stay updated with Hemostasis Today.
- 
                    Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
- 
                    Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
- 
                    Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
- 
                    Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
- 
                    Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
- 
                    Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
- 
                    Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
- 
                    Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
- 
                    Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
- 
                    Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
- 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
- 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
- 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
- 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
- 
                    Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
- 
                    Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
- 
                    Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
- 
                    Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
- 
                    Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
- 
                    Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague
